Insulet Corporation (PODD) PT Raised to $225 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Insulet (PODD) Misses Q4 EPS by 3c, Revenues Beat
February 25, 2020 4:05 PM ESTInsulet (NASDAQ: PODD) reported Q4 EPS of $0.08, $0.03 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $209.4 million versus the consensus estimate of $199.5 million.
Fourth quarter 2019 revenue of $209.4 million, up 27% compared to $164.9 million in the prior year, exceeds guidance of $193 to $201 millionTotal Omnipod revenue of $192.5 million, an increase of... More